Meeting Banner
Abstract #4332

Serial Whole-Brain N-Acetylaspartate Concentration in Multiple Sclerosis Patients

Daniel Rigotti1, Matilde Inglese1, Nissa Perry1, James Babb1, Joseph Herbert2, Oded Gonen1

1Radiology, NYU School of Medicine, New York, NY, United States; 2Neurology, NYU School of Medicine, New York, NY, United States


The irreversible effects of multiple sclerosis are chiefly caused by neuronal loss. The global concentration of the neuron-specific amino-acid derivative N-acetylaspartate (WBNAA1) has been shown to be a sensitive marker for diffuse neurodegeneration in cross-sectional studies. Here we show data from a year-long longitudinal study of nineteen newly-diagnosed MS patients where we detect a significant and biologically relevant serial decline in WBNAA. This is the first time, to our knowledge, that quantifiable changes reflecting ongoing pathogenesis have been measured in MS using WBNAA.

Keywords

concentrationbrain